Stay updated on Pembrolizumab in Lymphoma Subtypes Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Lymphoma Subtypes Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Lymphoma Subtypes Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.3 and no longer shows Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T20:08:03.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Page updated to Revision: v3.4.2. The previous funding-status notice (v3.4.1) and related operating-status messaging have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T05:09:27.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a government funding lapse notice and updated the page revision from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T04:05:28.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Glossary display added; QC-related field labels and FEAR Act labeling adjusted; page revision tag updated to v3.4.0.
    Difference
    0.2%
    Check dated 2026-01-28T00:49:14.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Page revision updated to v3.3.4 (replacing v3.3.3); this appears to be a minor site update with no changes to study content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:24:41.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Added the Maryland location under Locations and updated the page revision to v3.3.3. Removed the Maryland Locations footer item and the HHS Vulnerability Disclosure link.
    Difference
    0.2%
    Check dated 2025-12-23T07:55:22.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Lymphoma Subtypes Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Lymphoma Subtypes Clinical Trial page.